Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;44(7):441-7.
doi: 10.1038/bmt.2009.56. Epub 2009 Mar 23.

Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome

Affiliations

Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome

M Sakai et al. Bone Marrow Transplant. 2009 Oct.

Abstract

Hepatic complications of transplant are a common cause of mortality. Although mild elevations of serum aminotransferase enzymes (aspartate and alanine (AST, ALT)) do not carry an adverse prognosis, this is not the case with severe hepatocellular injury. We reviewed 6225 consecutive recipients to determine the incidence and outcomes of severe hepatocellular injury (AST >1500 U/l) before day 100, which occurred in 88 patients. Causes were sinusoidal obstruction syndrome (SOS) (n = 46), hypoxic hepatitis (n = 33), varicella zoster virus (VZV) hepatitis (n = 4), drug-liver injury (n = 2) and unknown (n = 3). The incidence declined from 1.9% in the 1990s to 1.1% recently (owing to a fivefold decline in SOS and disappearance of VZV hepatitis). In hypoxic hepatitis, peak serum AST was 3545 U/l (range, 1380-25 246) within days of shock or prolonged hypoxemia; case fatality rate was 88%. In SOS, AST increases occurred 2-6 weeks after diagnosis; peak AST was 2252 U/l (range, 1437-8281); case fatality rate was 76%, with only serum bilirubin able to distinguish survivors (2.7 vs 11.3 mg/100 ml, P=0.0009). We conclude that circulatory insults (sinusoidal injury, hypotension and hypoxemia), and not infection, are the most common cause of severe hepatocellular injury, the frequency of which has declined because of a falling incidence of SOS and VZV hepatitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Photomicrographs of liver tissue illustrating causes of severe hepatitis following hematopoietic cell transplant. A. Sinusoidal Obstruction Syndrome. A liver acinus is shown here, with a central vein on the left; diffuse hepatocyte necrosis in zone 3, surrounding the vein (the area within the arc); and deposition of collagens within sinusoids in zone 2 of the acinus (outside the arc). Masson trichrome. B. Hypoxic hepatitis following respiratory failure and hypotension. Zones 2 and 3 of a liver acinus, with the central vein in the lower right. Numerous hepatocytes that have lost nuclei as a result of ischemia are seen in zone 3; arrows point to some of these dying cells. Hematoxylin and eosin. C. Varicella zoster virus infection. The left panel illustrates a punched-out area of confluent hepatocyte necrosis without distinguishing features (hematoxylin and eosin); the right panel shows reaction product from staining with a monoclonal antibody to VZV (immunohistochemistry). D. Unknown. There is a large circular area of confluent hepatocyte necrosis surrounded by normal hepatocytes. There were no areas of viral cytopathic effect, and immunohistochemical stains were negative for viruses. Masson trichrome.

Similar articles

Cited by

References

    1. Strasser SI, McDonald GB. Gastrointestinal and hepatic complications. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, editors. Thomas' Hematopoietic Cell Transplantation. Fourth. Oxford, UK: Wiley-Blackwell Publishing; 2009. pp. 1434–1455.
    1. Gooley TA, Rajvanshi P, Schoch HG, McDonald GB. Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation. Hepatology. 2005;41:345–52. - PubMed
    1. El-Sayed MH, El-Haddad A, Fahmy OA, Salama II, Mahmoud HK. Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation. European Journal of Gastroenterology & Hepatology. 2004;16:1347–54. - PubMed
    1. Kim B, Chung K, Sun H, Suh J, Min W, Kang C, et al. Liver disease during the first posttransplant year in bone marrow transplantation recipients: retrospective study. Bone Marrow Transplantation. 2000;26:193–7. - PubMed
    1. McDonald GB. Management of hepatic disease following hematopoietic cell tranplant. Alimentary Pharmacology & Therapeutics. 2006;24:441–52. - PubMed

Publication types

MeSH terms